PortfoliosLab logoPortfoliosLab logo
Sensus Healthcare, Inc. (SRTS)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US81728J1097
CUSIP
81728J109
IPO Date
Jun 3, 2016

Highlights

Market Cap
$64.98M
Enterprise Value
$43.84M
EPS (TTM)
-$0.47
Total Revenue (TTM)
$27.48M
Gross Profit (TTM)
$11.87M
EBITDA (TTM)
-$6.71M
Year Range
$3.03 - $5.92
Target Price
$10.00
ROA (TTM)
-14.55%
ROE (TTM)
-16.05%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Sensus Healthcare, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Sensus Healthcare, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Sensus Healthcare, Inc. (SRTS) has returned -0.00% so far this year and -15.86% over the past 12 months.


Sensus Healthcare, Inc.

1D
2.84%
1M
-3.16%
YTD
-0.00%
6M
26.75%
1Y
-15.86%
3Y*
-8.59%
5Y*
0.67%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jul 26, 2016, SRTS's average daily return is +0.10%, while the average monthly return is +1.46%. At this rate, your investment would double in approximately 4.0 years.

Historically, 47% of months were positive and 53% were negative. The best month was Nov 2021 with a return of +53.5%, while the worst month was Nov 2022 at -52.5%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 7 months.

On a daily basis, SRTS closed higher 47% of trading days. The best single day was May 10, 2024 with a return of +38.9%, while the worst single day was Nov 4, 2022 at -51.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202628.89%-19.88%-3.16%-0.00%
202519.00%-41.96%-1.05%-9.09%10.70%-0.42%17.93%-39.36%-7.37%1.59%31.35%-5.01%-42.49%
202437.71%26.15%-7.32%-1.05%44.15%-1.66%19.51%2.35%-11.04%10.34%32.97%-18.68%193.22%
202323.18%-24.84%-24.16%-9.21%-43.13%17.10%-4.76%3.67%-10.93%-20.94%10.50%-2.48%-68.19%
20226.79%36.58%-3.89%-30.24%22.80%-11.42%46.61%10.57%0.64%12.29%-52.52%11.08%2.77%
2021-3.11%22.19%-16.19%0.52%-6.49%6.94%-3.64%-4.04%1.12%11.11%53.50%17.59%87.05%

Benchmark Metrics

Sensus Healthcare, Inc. has an annualized alpha of 15.06%, beta of 0.78, and R² of 0.04 versus S&P 500 Index. Calculated based on daily prices since July 27, 2016.

  • This stock participated in 97.97% of S&P 500 Index downside but only 36.79% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.04 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
15.06%
Beta
0.78
0.04
Upside Capture
36.79%
Downside Capture
97.97%

Return for Risk

Risk / Return Rank

SRTS ranks 31 for risk / return — below 31% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


SRTS Risk / Return Rank: 3131
Overall Rank
SRTS Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
SRTS Sortino Ratio Rank: 3333
Sortino Ratio Rank
SRTS Omega Ratio Rank: 3434
Omega Ratio Rank
SRTS Calmar Ratio Rank: 2929
Calmar Ratio Rank
SRTS Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Sensus Healthcare, Inc. (SRTS) and compare them to a chosen benchmark (S&P 500 Index).


SRTSBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.22

0.90

-1.12

Sortino ratio

Return per unit of downside risk

0.20

1.39

-1.19

Omega ratio

Gain probability vs. loss probability

1.03

1.21

-0.18

Calmar ratio

Return relative to maximum drawdown

-0.37

1.40

-1.76

Martin ratio

Return relative to average drawdown

-0.61

6.61

-7.22

Explore SRTS risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Sensus Healthcare, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Sensus Healthcare, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Sensus Healthcare, Inc. was 87.51%, occurring on Nov 13, 2023. The portfolio has not yet recovered.

The current Sensus Healthcare, Inc. drawdown is 73.41%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.51%Aug 15, 2022315Nov 13, 2023
-80.17%Mar 18, 2019294May 14, 2020443Feb 15, 2022737
-46.56%Aug 16, 2016235Jul 21, 2017197May 3, 2018432
-40.37%Mar 25, 202225Apr 29, 202267Aug 5, 202292
-39.11%Oct 2, 201842Nov 29, 201871Mar 15, 2019113

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Sensus Healthcare, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Sensus Healthcare, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for SRTS relative to other companies in the Medical Devices industry. Currently, SRTS has a P/S ratio of 2.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for SRTS in comparison with other companies in the Medical Devices industry. Currently, SRTS has a P/B value of 1.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items